Aarey Drugs & Pharmaceuticals

₹109.21As of Sun 8 Nov 2026, 12:00 UTC

NSE:AAREYDRUGSHealthcare

Country India

PE (Fwd) 77.93

TSR 5Y CAGR 22.88%

Div yield —

ROE —

Drug Manufacturers (Specialty & Generic)

Beta (5Y) 1.24

PE TTM 78.32

TSR TTM 14.99%

Mkt cap ₹3.100B

ROIC —

SE Grade™

—

Value

Quality

Moat

—

1Y Price

Reference

₹122

11.53%

(93.08%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

4.723

Revenue₹B

—

4.929

4.190

4.026

4.739

4.723

4.773

(1.06%)

(0.35)

Revenue growth%

—

(15.01)

(3.91)

17.73

(0.35)

1.06

(2.13)

—

3.74

Gross margin%

—

4.23

3.60

5.13

2.49

3.74

3.72

3.74

1.22

Operating margin%

—

2.03

1.60

2.43

1.08

1.22

1.21

1.60

0.84

Net margin%

—

1.33

0.90

1.16

0.85

0.84

0.83

0.90

78.32

P/E ratio (avg)x

—

16.71

24.73

24.52

42.88

49.68

78.76

24.73

53.76

EV/EBITx

—

10.92

13.94

11.75

33.72

34.10

53.79

13.94

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

1.39

EPS₹

—

2.72

1.48

1.84

1.41

1.39

(15.40%)

—

(1.40)

EPS growth%

—

(45.64)

24.52

(23.27)

(1.40)

(0.55)

(12.33)

—

Bookvalue per sh₹

—

FCF per share₹

—

Dividend per sh₹

—

Div yield (avg)%

—

Payout ratio%

—

28.45

Shares (diluted)M

—

24.07

25.48

25.41

28.45

◌28.45

4.27%

—

Buyback yield%

—

(5.84)

0.26

(11.96)

—

◌—

(2.92)

—

D/E ratiox

—

3.107

Enterprise value₹B

—

1.095

0.933

1.148

1.725

1.971

3.107

15.83%

—

LT debt₹M

—

Peers (US$33.05M)

Cap (US$)

Albert David Limited

48.20M

19.65x

Medicamen Biotech…

39.77M

37.01x

Nectar Lifesciences…

20.93M

—

Little Green Pharma Ltd

32.98M

4.979x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

1.346

2.329

Own earn%

—

Sh yield%

—

(2.92)

Owners

Insiders/Inst%

47.88

2.78

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

1/4

EPS growth years

1/4

Dividend streakyrs

Op margin range%

1–2

$1 testx

—

Incr. ROIC%

—

Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹4.723B

(1.06%)

1.00×

Cost of revenue

₹4.546B

(0.94%)

1.01×

Operating expenses

₹118.9M

2.38%

1.15×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m